Source: MarketScreener

Just.: Evotec : Just - Evotec Biologics partners with ABL on development of broadly neutralising antibody against HIV

(marketscreener.com) Just - Evotec Biologics partners with ABL on development of broadly neutralising antibody against HIV JUST - EVOTEC BIOLOGICS TO PROVIDE PROCESS DEVELOPMENT REQUIRED FOR PHASE I CGMP CLINICAL MANUFACTURING OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV ...https://www.marketscreener.com/EVOTEC-SE-436047/news/Evotec-Just-Evotec-Biologics-partners-with-ABL-on-development-of-broadly-neutralising-antibody-a-30738693/?utm_medium=RSS&utm_content=20200608

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
James N. Thomas's photo - President & CEO of Just.

President & CEO

James N. Thomas

CEO Approval Rating

83/100

Read more